-
公开(公告)号:US10973884B2
公开(公告)日:2021-04-13
申请号:US15087563
申请日:2016-03-31
发明人: Mi Sun Won , Hyun Seung Ban , Bo Kyung Kim , Soon Woo Nam , Kyeong Lee , Young-Ju Lee , Hong-Sub Lee , Dong Uk Kim , Ki Cheol Park , Joo-Young Im , Kyoung-Jin Oh
IPC分类号: A61K38/44 , C12N9/02 , C12N7/00 , G01N33/574 , A61K48/00
摘要: The present invention relates to a pharmaceutical composition for treating cancer, containing cytochrome b5 reductase 3 (CYB5R3) protein as an active ingredient. Over-expression of CYB5R3 in cancer cells results in significant reduction of hypoxia-inducible factor-1α (HIF-1α) expression, which leads inhibition of cancer cells growth in vitro and in vivo. Thus, the CYB5R3 gene or protein of the present invention can be useful as an active ingredient of a pharmaceutical composition for treating cancer.